Novel transcript, antisense to KRBA2 and RPL26 (ENSG00000265749)

ENSG00000265749 is described in public resources as a novel antisense RNA transcript with sequence complementarity to the coding loci of the KRBA2 and RPL26 genes. Antisense RNAs are generally non-coding RNAs that may influence the expression, stability, or processing of the overlapping "sense" RNAs through various mechanisms such as transcriptional interference or modulation of chromatin structure. For this specific transcript, neither detailed experimental function nor disease association has been reported in curated biomedical sources as of the latest updates. There are no known interacting drugs or established use as a biomarker. This entity lacks a formal canonical abbreviation and is not classified as a conventional therapeutic target (such as a receptor, enzyme, transporter, etc.), and is often listed simply as a "novel transcript" in large gene expression datasets. There is something inherently incorrect or incomplete in treating ENSG00000265749 as a conventional target: it is a non-protein-coding, uncharacterized antisense RNA with no evidence for therapeutic targeting or biomarker applications. If your use case requires gene or protein targets for pharmacological intervention, this entry does not match those criteria.

None established; typical mechanisms for antisense transcripts include regulation of sense transcript stability and transcription rates